Screener
Bio-Rad Laboratories BIO Compensation and benefits
Compensation and benefits at other companies
Other financials
Where this comes from
Reported directly by Bio-Rad Laboratories in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensation.
The source filing: Bio-Rad Laboratories’s 10-Q, filed April 30, 2026.
- Filed
- Apr 30, 2026, 4:19 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000012208-26-000035
| Line item | Three Months Ended / March 31, 2026 | Three Months Ended / March 31, 2025 |
|---|---|---|
| Adjustments to reconcile net income (loss) to net cash provided by operating activities: | ||
| Depreciation and amortization | 40.9 | 38.1 |
| Reduction in the carrying amount of right-of-use assets | 9.7 | 10.1 |
| Share-based compensation | 15.0 | 15.3 |
| (Gains) losses from change in fair market value of equity securities and loan receivable | 738.2 | (31.8) |
| Payments for operating lease liabilities | (10.6) | (11.0) |
| Decrease in accounts receivable | 30.8 | 37.2 |
| Increase in inventories | (29.9) | (17.9) |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Bio-Rad Laboratories's compensation and benefits?
- Bio-Rad Laboratories (BIO) reported compensation and benefits of $15M in Q1 2026.
- How has Bio-Rad Laboratories's compensation and benefits changed year-over-year?
- Bio-Rad Laboratories's compensation and benefits decreased by 2.0% year-over-year, from $15.3M to $15M.
- What does compensation and benefits mean?
- Total employee-related costs including salaries, wages, bonuses, commissions, stock-based compensation, health insurance, retirement contributions, and payroll taxes.
Ask your AI about Bio-Rad Laboratories's compensation and benefits.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude